{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:01:23Z","timestamp":1765404083391,"version":"3.46.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,10]]},"DOI":"10.7759\/cureus.98919","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T21:59:03Z","timestamp":1765403943000},"source":"Crossref","is-referenced-by-count":0,"title":["Early Initiation of Sacubitril\/Valsartan in Intracerebral Hemorrhage With Refractory Hypertension and Chronic Heart Failure: A Case Report"],"prefix":"10.7759","author":[{"given":"Takeru","family":"Nishino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumu","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinori","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Mikuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/str.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill JC 3rd","year":"2015","unstructured":"Hemphill JC 3rd, Greenberg SM, Anderson CS, et al.. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015, 46:2032-60. 10.1161\/str.0000000000000069","journal-title":"Stroke"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.124.048189","article-title":"Incidence and outcomes of patients with early cardiac complications after intracerebral hemorrhage: a report from VISTA","volume":"55","author":"Ishiguchi H","year":"2024","unstructured":"Ishiguchi H, Huang B, El-Bouri WK, et al.. Incidence and outcomes of patients with early cardiac complications after intracerebral hemorrhage: a report from VISTA. Stroke. 2024, 55:2669-76. 10.1161\/strokeaha.124.048189","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv142","article-title":"Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials","volume":"36","author":"Bavishi C","year":"2015","unstructured":"Bavishi C, Messerli FH, Kadosh B, et al.. Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials. Eur Heart J. 2015, 36:1967-73. 10.1093\/eurheartj\/ehv142","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12667","article-title":"LCZ696, a first-in-class angiotensin receptor-Neprilysin inhibitor: the first clinical experience in patients with severe hypertension","volume":"18","author":"Kario K","year":"2016","unstructured":"Kario K, Tamaki Y, Okino N, et al.. LCZ696, a first-in-class angiotensin receptor-Neprilysin inhibitor: the first clinical experience in patients with severe hypertension. J Clin Hypertens (Greenwich). 2016, 18:308-14. 10.1111\/jch.12667","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-021-00819-7","article-title":"Efficacy of sacubitril\/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study","volume":"45","author":"Rakugi H","year":"2022","unstructured":"Rakugi H, Kario K, Yamaguchi M, et al.. Efficacy of sacubitril\/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study. Hypertens Res. 2022, 45:824-33. 10.1038\/s41440-021-00819-7","journal-title":"Hypertens Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-025-02331-8","article-title":"Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)","volume":"48","author":"Ohya Y","year":"2025","unstructured":"Ohya Y, Sakima A, Arima H, et al.. Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025). Hypertens Res. 2025, 48:2500-11. 10.1038\/s41440-025-02331-8","journal-title":"Hypertens Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/17474930221090347","article-title":"Japan stroke society guideline 2021 for the treatment of stroke","volume":"17","author":"Miyamoto S","year":"2022","unstructured":"Miyamoto S, Ogasawara K, Kuroda S, et al.. Japan stroke society guideline 2021 for the treatment of stroke. Int J Stroke. 2022, 17:1039-49. 10.1177\/17474930221090347","journal-title":"Int J Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/heartasia-2018-011139","article-title":"Impact of heart failure on stroke mortality and recurrence","volume":"11","author":"Pana TA","year":"2019","unstructured":"Pana TA, Wood AD, Perdomo-Lampignano JA, et al.. Impact of heart failure on stroke mortality and recurrence. Heart Asia. 2019, 11:e011139. 10.1136\/heartasia-2018-011139","journal-title":"Heart Asia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1643","article-title":"Left ventricular ejection fraction as an independent predictor of poor outcome in acute intracerebral hemorrhage","volume":"10","author":"Yang G","year":"2020","unstructured":"Yang G, Wang L, Sun J, et al.. Left ventricular ejection fraction as an independent predictor of poor outcome in acute intracerebral hemorrhage. Brain Behav. 2020, 10:e01643. 10.1002\/brb3.1643","journal-title":"Brain Behav"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-25-0002","article-title":"JCS\/JHFS 2025 guideline on diagnosis and treatment of heart failure","volume":"89","author":"Kitai T","year":"2025","unstructured":"Kitai T, Kohsaka S, Kato T, et al.. JCS\/JHFS 2025 guideline on diagnosis and treatment of heart failure. Cir Jr. 2025, 89:1278-444. 10.1253\/circj.CJ-25-0002","journal-title":"Cir Jr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0885066616683677","article-title":"N-terminal pro-brain natriuretic peptide concentrations after hypertensive intracerebral hemorrhage: relationship with hematoma size, hyponatremia, and intracranial pressure","volume":"33","author":"Li F","year":"2018","unstructured":"Li F, Chen QX, Xiang SG, et al.. N-terminal pro-brain natriuretic peptide concentrations after hypertensive intracerebral hemorrhage: relationship with hematoma size, hyponatremia, and intracranial pressure. J Intensive Care Med. 2018, 33:663-70. 10.1177\/0885066616683677","journal-title":"J Intensive Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.05.012","article-title":"NT-proBNP response to Sacubitril\/Valsartan in hospitalized heart failure patients with reduced ejection fraction: TRANSITION study","volume":"8","author":"Pascual-Figal D","year":"2020","unstructured":"Pascual-Figal D, Wachter R, Senni M, et al.. NT-proBNP response to Sacubitril\/Valsartan in hospitalized heart failure patients with reduced ejection fraction: TRANSITION study. JACC Heart Fail. 2020, 8:822-33. 10.1016\/j.jchf.2020.05.012","journal-title":"JACC Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-Neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez EJ","year":"2019","unstructured":"Velazquez EJ, Morrow DA, DeVore AD, et al.. Angiotensin-Neprilysin inhibition in acute decompensated heart failure. N Engl J Med. 2019, 380:539-48. 10.1056\/NEJMoa1812851","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21037\/apm-22-483","article-title":"Implication of sacubitril\/valsartan on N-terminal pro B-type natriuretic peptide levels in hypertensive patients","volume":"11","author":"Imamura T","year":"2022","unstructured":"Imamura T, Kinugawa K. Implication of sacubitril\/valsartan on N-terminal pro B-type natriuretic peptide levels in hypertensive patients. Ann Palliat Med. 2022, 11:2856-61. 10.21037\/apm-22-483","journal-title":"Ann Palliat Med"},{"key":"ref15","unstructured":"Cardene Nicardipine Hydrochloride. Label. (2025). Accessed: December 10, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/019734s030lbl.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study","volume":"375","author":"Ruilope LM","year":"2010","unstructured":"Ruilope LM, Dukat A, B\u00f6hm M, et al.. Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. Lancet. 2010, 375:1255-66. 10.1016\/s0140-6736(09)61966-8","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-2-166","article-title":"Management of acute intracerebral haemorrhage - an\u00a0update","volume":"17","author":"Law ZK","year":"2017","unstructured":"Law ZK, Appleton JP, Bath PM, Sprigg N. Management of acute intracerebral haemorrhage - an\u00a0update. Clin Med (Lond). 2017, 17:166-72. 10.7861\/clinmedicine.17-2-166","journal-title":"Clin Med (Lond)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000213560","article-title":"Triple antihypertensive medication prediction score after intracerebral hemorrhage (the TRICH score)","volume":"104","author":"So CH","year":"2025","unstructured":"So CH, Yeung C, Ho RW, et al.. Triple antihypertensive medication prediction score after intracerebral hemorrhage (the TRICH score). Neurology. 2025, 104:213560. 10.1212\/wnl.0000000000213560","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/436875-early-initiation-of-sacubitrilvalsartan-in-intracerebral-hemorrhage-with-refractory-hypertension-and-chronic-heart-failure-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T21:59:04Z","timestamp":1765403944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/436875-early-initiation-of-sacubitrilvalsartan-in-intracerebral-hemorrhage-with-refractory-hypertension-and-chronic-heart-failure-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.98919","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}